BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 20093095)

  • 1. T and B cells target identical regions of the non-collagenous domain 1 of type VII collagen in epidermolysis bullosa acquisita.
    Müller R; Dahler C; Möbs C; Wenzel E; Eming R; Messer G; Niedermeier A; Hertl M
    Clin Immunol; 2010 Apr; 135(1):99-107. PubMed ID: 20093095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita.
    Komorowski L; Müller R; Vorobyev A; Probst C; Recke A; Jonkman MF; Hashimoto T; Kim SC; Groves R; Ludwig RJ; Zillikens D; Stöcker W; Schmidt E
    J Am Acad Dermatol; 2013 Mar; 68(3):e89-95. PubMed ID: 22341608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and disease severity assessment of epidermolysis bullosa acquisita by ELISA for anti-type VII collagen autoantibodies: an Italian multicentre study.
    Marzano AV; Cozzani E; Fanoni D; De Pità O; Vassallo C; Berti E; Parodi A; Crosti C; Cugno M
    Br J Dermatol; 2013 Jan; 168(1):80-4. PubMed ID: 22913489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
    Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
    J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermolysis bullosa acquisita sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: study using immunoblotting of domain-specific recombinant proteins and postembedding immunoelectron microscopy.
    Ishii N; Yoshida M; Hisamatsu Y; Ishida-Yamamoto A; Nakane H; Iizuka H; Tanaka T; Hashimoto T
    Br J Dermatol; 2004 May; 150(5):843-51. PubMed ID: 15149495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading.
    Fairley JA; Woodley DT; Chen M; Giudice GJ; Lin MS
    J Am Acad Dermatol; 2004 Jul; 51(1):118-22. PubMed ID: 15243536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some epidermolysis bullosa acquisita sera react with epitopes within the triple-helical collagenous domain as indicated by immunoelectron microscopy.
    Ishii N; Yoshida M; Ishida-Yamamoto A; Fritsch A; Elfert S; Bruckner-Tuderman L; Hashimoto T
    Br J Dermatol; 2009 May; 160(5):1090-3. PubMed ID: 19067699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis.
    Schmidt T; Hoch M; Lotfi Jad SS; Solimani F; Di Zenzo G; Marzano AV; Goebeler M; Cozzani E; Kern JS; Sitaru C; Lakoš Jukić I; Sárdy M; Uzun S; Jedlickova H; Gläser R; Kaneda M; Eming R; Göpel G; Ishii N; Greene B; Hashimoto T; Hertl M
    Br J Dermatol; 2017 Dec; 177(6):1683-1692. PubMed ID: 28703393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood epidermolysis bullosa acquisita with autoantibodies against the noncollagenous 1 and 2 domains of type VII collagen: case report and review of the literature.
    Mayuzumi M; Akiyama M; Nishie W; Ukae S; Abe M; Sawamura D; Hashimoto T; Shimizu H
    Br J Dermatol; 2006 Nov; 155(5):1048-52. PubMed ID: 17034540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients.
    Saleh MA; Ishii K; Kim YJ; Murakami A; Ishii N; Hashimoto T; Schmidt E; Zillikens D; Shirakata Y; Hashimoto K; Kitajima Y; Amagai M
    J Dermatol Sci; 2011 Jun; 62(3):169-75. PubMed ID: 21482078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions.
    Kim JH; Kim YH; Kim S; Noh EB; Kim SE; Vorobyev A; Schmidt E; Zillikens D; Kim SC
    J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e224-30. PubMed ID: 22731917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.
    Borradori L; Caldwell JB; Briggaman RA; Burr CE; Gammon WR; James WD; Yancey KB
    Arch Dermatol; 1995 May; 131(5):590-5. PubMed ID: 7741548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lupus band: do the autoantibodies target collagen VII?
    Alahlafi AM; Wordsworth P; Wojnarowska F
    Br J Dermatol; 2004 Mar; 150(3):504-10. PubMed ID: 15030334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmunity to type VII collagen in SKH1 mice is independent of regulatory T cells.
    Chen L; Peterson JD; Zheng WY; Lin SX; Chan LS
    Clin Exp Immunol; 2006 Aug; 145(2):322-31. PubMed ID: 16879253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel variant of acquired epidermolysis bullosa with autoantibodies against the central triple-helical domain of type VII collagen.
    Tanaka H; Ishida-Yamamoto A; Hashimoto T; Hiramoto K; Harada T; Kawachi Y; Shimizu H; Tanaka T; Kishiyama K; Höpfner B; Takahashi H; Iizuka H; Bruckner-Tuderman L
    Lab Invest; 1997 Dec; 77(6):623-32. PubMed ID: 9426400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial epidermolysis bullosa acquisita.
    Noe MH; Chen M; Woodley DT; Fairley JA
    Dermatol Online J; 2008 Dec; 14(12):2. PubMed ID: 19265615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermolysis bullosa acquisita: what's new?
    Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-type VII collagen autoantibodies, detected by enzyme-linked immunosorbent assay, fluctuate in parallel with clinical severity in patients with epidermolysis bullosa acquisita.
    Ito Y; Kasai H; Yoshida T; Saleh MA; Amagai M; Yamagami J
    J Dermatol; 2013 Nov; 40(11):864-8. PubMed ID: 24127822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita.
    Woodley DT; Chang C; Saadat P; Ram R; Liu Z; Chen M
    J Invest Dermatol; 2005 May; 124(5):958-64. PubMed ID: 15854036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 3 type VII collagen (C7) assays for serologic diagnosis of epidermolysis bullosa acquisita (EBA).
    Seta V; Aucouturier F; Bonnefoy J; Le Roux-Villet C; Pendaries V; Alexandre M; Grootenboer-Mignot S; Heller M; Lièvre N; Laroche L; Caux F; Titeux M; Hovnanian A; Prost-Squarcioni C
    J Am Acad Dermatol; 2016 Jun; 74(6):1166-72. PubMed ID: 26947449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.